+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BREO Ellipta Drugs Market by Mechanism Of Action (ICS, ICS/LABA, ICS/LAMA/LABA), Indication (Asthma, Asthma COPD Overlap, COPD), End User - Global Forecast 2025-2030- Product Image
BREO Ellipta Drugs Market by Mechanism Of Action (ICS, ICS/LABA, ICS/LAMA/LABA), Indication (Asthma, Asthma COPD Overlap, COPD), End User - Global Forecast 2025-2030- Product Image
Sale

BREO Ellipta Drugs Market by Mechanism Of Action (ICS, ICS/LABA, ICS/LAMA/LABA), Indication (Asthma, Asthma COPD Overlap, COPD), End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6013737
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The BREO Ellipta drugs market is set for measured, sustainable growth, driven by continuous therapeutic innovation and an increased emphasis on effective respiratory disease management. Stakeholders with interests in pharmaceuticals, healthcare provision, and supply chain strategy are closely watching this evolving segment as real-world trends in adherence, clinical efficacy, and access shape both regional and global opportunities.

Market Snapshot: Breo Ellipta Drugs Market Growth and Outlook

The Breo Ellipta drugs market grew from USD 3.18 billion in 2024 to USD 3.33 billion in 2025. It is expected to continue growing at a CAGR of 4.57%, reaching USD 4.16 billion by 2030. This growth is supported by Breo Ellipta’s established use in chronic respiratory management, strong healthcare acceptance, and regulatory momentum favoring combination inhalation therapies.

Scope & Segmentation of the Breo Ellipta Drugs Market

The report delivers granular insights by segmenting the market according to pharmacological action, clinical application, end-user setting, and region. These categories equip strategic planners with the clarity to tailor investments and operational initiatives.

  • Mechanism Of Action
    • Inhaled Corticosteroid (ICS)
    • ICS/Long-Acting Beta-Agonist (ICS/LABA): Fluticasone Furoate Vilanterol
    • ICS/Long-Acting Muscarinic Antagonist/LABA (ICS/LAMA/LABA): Fluticasone Furoate Umeclidinium Vilanterol
    • LABA
    • LAMA: Umeclidinium
    • LAMA/LABA: Umeclidinium Vilanterol
  • Indication
    • Asthma
    • Asthma COPD Overlap
    • COPD
  • End User
    • Homecare
    • Hospitals
    • Specialty Clinics
  • Regional Coverage
    • Americas: United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Key Companies
    • GlaxoSmithKline plc
    • AstraZeneca plc
    • Boehringer Ingelheim International GmbH
    • Novartis AG
    • Chiesi Farmaceutici S.p.A.
    • Teva Pharmaceutical Industries Ltd
    • Viatris Inc.
    • Cipla Ltd
    • Sun Pharmaceutical Industries Ltd
    • Lupin Limited

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Breo Ellipta’s dual therapy addresses the need for long-term management in asthma and COPD, with focus on adherence and patient outcomes.
  • Device innovation—including advanced inhaler technology—facilitates proper technique, enhancing both patient experience and therapeutic efficacy.
  • Regulatory agencies increasingly support rapid approval of combination therapies that streamline treatment regimens for respiratory conditions.
  • Adoption of digital health tools in respiratory care provides actionable, real-time adherence data, supporting more responsive clinical interventions.
  • Market segmentation reveals shifting trends toward home-based care, especially as remote monitoring and education tools improve patient engagement and reach.
  • Regional diversity shapes market uptake: mature markets prioritize innovation and outcomes, while emerging regions focus on cost efficiency, accessibility, and localized education programs.

Tariff Impact: United States 2025 Tariff Adjustments

In 2025, U.S. tariff changes on global pharmaceutical ingredients and device components triggered increased input costs and more complex logistics. Manufacturers responded by diversifying suppliers and investing in regional production facilities to ensure operational resilience. Strategies included localizing manufacturing, forming logistics partnerships, and enhancing customs processes to minimize supply disruptions and maintain product availability.

Methodology & Data Sources

This report uses a multi-source methodology. Secondary research includes peer-reviewed literature, regulatory documents, and industry white papers. Primary research comprises structured interviews with senior clinical, economic, and operational experts. Triangulation of public and proprietary data ensures that the findings are validated, objective, and actionable.

Why This Report Matters

  • Empowers senior stakeholders to make informed allocation decisions aligned with clinical needs and market access realities.
  • Facilitates strategic planning by uncovering trends in device innovation, supply chain adaptation, and patient-centric care.
  • Supports go-to-market strategies and partnership development through detailed segment, technology, and regional analysis.

Conclusion: Breo Ellipta in the Evolving Respiratory Market

Breo Ellipta maintains a pivotal role in modern respiratory management, balanced by robust operational responses to regulatory and market shifts. Strategic use of segmentation and technology is key to optimizing market reach, care outcomes, and stakeholder value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Uptake of real-world effectiveness data supporting BREO Ellipta in reducing COPD exacerbations across diverse populations
5.2. Shifting prescribing behavior towards BREO Ellipta as first-line maintenance therapy amid updated GINA asthma guidelines
5.3. Market resistance from emerging biologic therapies targeting eosinophilic phenotypes impacting Ellipta prescription rates
5.4. Pricing pressure from biosimilar inhaled corticosteroid combos challenging BREO Ellipta’s market share growth
5.5. Expansion of patient-assistance programs enhancing affordability and driving increased BREO Ellipta utilization among underinsured
5.6. Digital inhaler add-ons integration improving adherence monitoring for BREO Ellipta patients in remote disease management
5.7. Competitive positioning of triple therapy inhalers narrowing the market differentiation for BREO Ellipta in severe COPD
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. BREO Ellipta Drugs Market, by Mechanism Of Action
8.1. Introduction
8.2. ICS
8.3. ICS/LABA
8.3.1. Fluticasone Furoate Vilanterol
8.4. ICS/LAMA/LABA
8.4.1. Fluticasone Furoate Umeclidinium Vilanterol
8.5. LABA
8.6. LAMA
8.6.1. Umeclidinium
8.7. LAMA/LABA
8.7.1. Umeclidinium Vilanterol
9. BREO Ellipta Drugs Market, by Indication
9.1. Introduction
9.2. Asthma
9.3. Asthma COPD Overlap
9.4. COPD
10. BREO Ellipta Drugs Market, by End User
10.1. Introduction
10.2. Homecare
10.3. Hospitals
10.4. Specialty Clinics
11. Americas BREO Ellipta Drugs Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa BREO Ellipta Drugs Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific BREO Ellipta Drugs Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. GlaxoSmithKline plc
14.3.2. AstraZeneca plc
14.3.3. Boehringer Ingelheim International GmbH
14.3.4. Novartis AG
14.3.5. Chiesi Farmaceutici S.p.A.
14.3.6. Teva Pharmaceutical Industries Ltd
14.3.7. Viatris Inc.
14.3.8. Cipla Ltd
14.3.9. Sun Pharmaceutical Industries Ltd
14.3.10. Lupin Limited
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. BREO ELLIPTA DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. BREO ELLIPTA DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. BREO ELLIPTA DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. BREO ELLIPTA DRUGS MARKET: RESEARCHAI
FIGURE 22. BREO ELLIPTA DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 23. BREO ELLIPTA DRUGS MARKET: RESEARCHCONTACTS
FIGURE 24. BREO ELLIPTA DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BREO ELLIPTA DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY FLUTICASONE FUROATE VILANTEROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY FLUTICASONE FUROATE VILANTEROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY FLUTICASONE FUROATE UMECLIDINIUM VILANTEROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY FLUTICASONE FUROATE UMECLIDINIUM VILANTEROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LABA, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LABA, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY UMECLIDINIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY UMECLIDINIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY UMECLIDINIUM VILANTEROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY UMECLIDINIUM VILANTEROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ASTHMA COPD OVERLAP, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY ASTHMA COPD OVERLAP, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY COPD, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY COPD, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BREO ELLIPTA DRUGS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES BREO ELLIPTA DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 87. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 88. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 89. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 90. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 91. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 92. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 93. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 94. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 95. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 96. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 97. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. CANADA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 102. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 103. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 104. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 105. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 106. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 107. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 108. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 109. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 110. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 111. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 112. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 113. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. MEXICO BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 174. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 175. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 176. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 177. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 178. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 179. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 180. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 181. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 182. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 183. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 184. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 185. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. GERMANY BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 188. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 189. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 190. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 191. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 192. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 193. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 194. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 195. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 196. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 197. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 198. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 199. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. FRANCE BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 216. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 217. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 218. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 219. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 220. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 221. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 222. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 223. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 224. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 225. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 226. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 227. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. ITALY BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 230. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 231. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 232. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 233. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 234. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 235. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 236. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 237. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 238. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 239. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 240. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 241. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. SPAIN BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 258. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 260. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 272. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 274. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 286. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 287. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 288. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 289. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 290. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 291. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 292. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 293. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 294. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 295. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 296. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 297. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. DENMARK BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 300. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 314. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 315. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 316. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 317. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 318. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 319. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 320. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 321. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 322. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 323. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 324. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 325. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. QATAR BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 328. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 329. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 330. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 331. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 332. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 333. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 334. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 335. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 336. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 337. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 338. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 339. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 340. FINLAND BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 341. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2024 (USD MILLION)
TABLE 342. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025-2030 (USD MILLION)
TABLE 343. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2018-2024 (USD MILLION)
TABLE 344. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LABA, 2025-2030 (USD MILLION)
TABLE 345. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 346. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY ICS/LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 347. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2018-2024 (USD MILLION)
TABLE 348. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA, 2025-2030 (USD MILLION)
TABLE 349. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2018-2024 (USD MILLION)
TABLE 350. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY LAMA/LABA, 2025-2030 (USD MILLION)
TABLE 351. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 352. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 353. SWEDEN BREO ELLIPTA DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLI

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this BREO Ellipta Drugs market report include:
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Novartis AG
  • Chiesi Farmaceutici S.p.A.
  • Teva Pharmaceutical Industries Ltd
  • Viatris Inc.
  • Cipla Ltd
  • Sun Pharmaceutical Industries Ltd
  • Lupin Limited

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.33 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.16 Billion
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

TRELEGY ELLIPTA Market Size, Insight, and Forecast to 2032 - Product Image

TRELEGY ELLIPTA Market Size, Insight, and Forecast to 2032

  • Report
  • 30 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2025 - Product Image

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032 - Product Image

ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032

  • Report
  • 30 Pages
  • Global
From
Respiratory Inhalers Market by Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer), Drug Class (Combination Therapy, Inhaled Corticosteroid, Long-Acting Beta Agonist), Distribution Channel, Indication, Patient Age Group - Global Forecast 2025-2030 - Product Image

Respiratory Inhalers Market by Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer), Drug Class (Combination Therapy, Inhaled Corticosteroid, Long-Acting Beta Agonist), Distribution Channel, Indication, Patient Age Group - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease Treatment Market by Product Type (Antibiotics, Corticosteroids, Long Acting Bronchodilators), Drug Class (Anticholinergics, Beta Agonists, Corticosteroids), Route Of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Chronic Obstructive Pulmonary Disease Treatment Market by Product Type (Antibiotics, Corticosteroids, Long Acting Bronchodilators), Drug Class (Anticholinergics, Beta Agonists, Corticosteroids), Route Of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.